Amino acid transporters are upregulated in the different types of cancer, and many of them, such as CD98hc/SCL3A2, LAT1/SLC7A5, ASCT2/SLC1A5, emerged as promising molecular biomarkers, therapeutic targets, and novel tools for tumor imaging. This evidence concerns the gene SLC3A2 and neoplasm.